Valter Longo
Longo helped move fasting biology from aging mechanisms into fasting-mimicking diets and human trials. His 348 works have drawn 37,268 citations, though clinical adoption remains unproven.
Profile
Professor at the University of Southern California and director of the USC Longevity Institute whose research examines fasting, nutrition, and nutrient-sensing pathways in aging and disease.
Role
scientisthigh confidence
Longo authored a large body of peer-reviewed research advancing fasting biology, healthspan, and aging interventions; the documented papers include mechanistic, preclinical, review, and human-trial work.
Dimension breakdown
This score rates longevity commitment only. The role tags above — scientist, investor, and the rest — say what this person is; we don't score those separately.
Future vision
7.0/ 10
Longo presents a durable, translational vision of extending healthy lifespan by modulating conserved nutrient-sensing and stress-resistance pathways, particularly through periodic fasting-mimicking diets. The vision is scientifically specific and consistently reflected across his research, but the evidence lacks a clearly stated destination, quantitative lifespan target, development timeline, or comprehensive account of risks and barriers.
medium confidence
Scientific impact
9.0/ 10
OpenAlex metrics indicate field-defining scientific influence: an h-index of 89, 37,268 citations, and numerous highly cited works spanning foundational aging mechanisms, fasting biology, nutrition, and human health. Multiple papers have received roughly 700–3,000 citations, demonstrating sustained influence beyond publication volume. The evidence supports exceptional impact, though not a perfect score because no clinical trials were identified and the supplied recent papers do not independently establish broad clinical adoption.
high confidence
Capital deployed
N/A
The evidence documents substantial scientific activity but identifies no investments, donations, catalytic positions, or capital-backed longevity outcomes to evaluate under this dimension.
No public investment or donation activity is evidenced; the record characterizes Longo as a scientist rather than a capital deployer.
high confidence
Strategic taste
6.5/ 10
Longo shows a coherent, sustained strategy linking nutrient-sensing and fasting biology to practical interventions across aging and disease. The progression from foundational yeast research to fasting-mimicking diets and clinical applications suggests strong thesis formation and translational judgment. However, the supplied evidence does not establish how early or contrarian these choices were, demonstrate clear counterfactual field impact, or substantiate L-Nutra's founding and outcomes.
medium confidence
Field creation
5.0/ 10
Longo has made fasting-mimicking diets a recognizable translational protocol and is associated with institutional and commercial vehicles for longevity research. However, the supplied evidence does not independently establish that he founded the USC Longevity Institute or L-Nutra, nor demonstrate their scale, activity, or broader field-building effects.
medium confidence
Bravery and conviction
3.0/ 10
Longo shows limited but credible contrarian conviction by publicly advancing a framework that challenges conventional aging-centered thinking and by sustaining a research program around fasting-based interventions. However, the evidence does not establish serious personal risk, career sacrifice, sustained resistance to public criticism, or self-experimentation.
medium confidence
Multiplier effect
7.0/ 10
Longo demonstrates substantial second-order leverage through a highly influential research corpus, extensive cross-institutional collaboration, leadership of the USC Longevity Institute, and creation of L-Nutra as a vehicle for translating fasting research beyond academia. However, the evidence does not establish field-defining effects on capital, policy, talent formation, or founder creation.
medium confidence
Vision
Destination
No canonical quotes yet.
Path
Fasting-mimicking diet (FMD) cycles, defined as 3-5 day periods of a calorie-restricted, low-protein, low-carbohydrate, and high-fat diet, have emerged as a dietary approach to delay cancer initiation and progression
Overall, the effect of proteasome inhibition in combination with FMD cycles in promoting CLL death supports the targeting of starvation escape pathways as an effective treatment strategy that should be tested in clinical trials.
He is also interested in identifying the molecular pathways conserved from simple organisms to humans that can be modulated to protect against multiple stresses and treat or prevent cancer, Alzheimer’s Disease and other diseases of aging.
Publicly endorses Fasting-mimicking metabolic switch
Strategy
Translate research on fasting, nutrition, and nutrient-sensing pathways into interventions targeting aging and disease.
Longo's evidenced strategy centers on translating fasting, nutrition, and nutrient-sensing biology into longevity and disease interventions [S1]. His academic base at the University of Southern California and leadership of the USC Longevity Institute indicate a research-led approach [S1]. Founding L-Nutra provides the only documented organizational vehicle for applying this work beyond academia [S2]. No evidence supports a preferred investment stage, geography, risk appetite, time horizon, or specific collaborator network [S2]. No investments or donations were identified in the supplied evidence [S2].
UnknownUnknownFasting BiologyNutritionNutrient SensingAgingDisease Intervention
Notable bets
Portfolio
Investments
No public rows yet.
Donations
No public rows yet.
Organizations founded
Scientific output
h-index89
Citations-
Papers23
Trials0
Bravery and conviction
Belief evolution
Connections
Companies
Collaborators and lineage
No public rows yet.
Criticisms